Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2018-11-19 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于向成都银行申请综合授信的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (653 characters) regarding the company's application for a comprehensive credit facility with a bank. It details the credit amount, collateral, and authorization for handling the credit facility. There is no financial data, no report attached or referenced as being published, and no detailed financial statements or analysis. This fits the description of a Capital/Financing Update, as it concerns financing activities and credit arrangements.
2018-11-19 Chinese
独立董事关于公司购买房产暨关联交易的事前认可意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from independent directors regarding a proposed related-party transaction involving the company's purchase of real estate. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange listing rules. The document is short (716 characters) and consists mainly of an approval opinion rather than detailed financial data or a full report. It does not contain financial statements or comprehensive analysis, nor is it a report publication announcement. This type of document fits best under Regulatory Filings (RNS), as it is a compliance-related disclosure about a corporate transaction and independent director approval, not a full audit, annual, or interim report.
2018-11-19 Chinese
关于购买房产暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's purchase of real estate from a related party, specifically a director of the company. It includes information about the transaction, pricing, approvals by the board and independent directors, and compliance with stock exchange rules. The document is not a financial report, earnings release, or management discussion, but rather a disclosure of a related-party transaction involving capital assets. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement about a capital transaction and related-party dealings. The most appropriate classification is 'Capital/Financing Update (CAP)' because it concerns a significant capital asset purchase and related-party transaction disclosure.
2018-11-19 Chinese
第二届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the company's second board of directors' third meeting, including approval of property purchase, related party transactions, and loan applications. It includes voting results and references to further detailed disclosures on external websites and newspapers. The document is relatively short (1677 characters) and primarily serves to inform about board decisions rather than providing detailed financial data or full reports. It does not contain financial statements or comprehensive management discussion. Therefore, it fits best under 'Board/Management Information' (MANG), which covers announcements of changes or decisions by the board of directors.
2018-11-19 Chinese
独立董事关于第二届董事会第三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding specific board meeting matters, including property purchase, bank credit applications, and related approvals. It references compliance with company articles, stock exchange rules, and legal regulations. The content focuses on board-level approvals and opinions rather than financial results or detailed financial statements. The document length is short (1300 characters), and it is not a full financial report or earnings release. It is not a regulatory filing or announcement of a report but a formal board/management information disclosure about decisions and opinions on corporate matters. Therefore, the most appropriate classification is Board/Management Information (MANG).
2018-11-19 Chinese
华西证券股份有限公司关于公司购买房产暨关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from a sponsoring securities company (华西证券股份有限公司) regarding a related-party transaction involving the purchase of real estate by 西藏易明西雅医药科技股份有限公司. It includes transaction background, related party details, property details, pricing policy, and the sponsor's verification opinion. The document is not a financial report, earnings release, or regulatory filing but a specific audit or verification report on a related-party transaction. It does not announce a report publication but provides the actual verification opinion. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on a specific transaction, including compliance with regulatory rules and fairness opinions. FY 2018
2018-11-19 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.